Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Phase 1 Dose Finding Study of TTAX03 for the Treatment of Lumbosacral Facet Joint Pain

NCT06236308 is registered in ClinicalTrials.gov with BioTissue Holdings, Inc as lead sponsor.

NCT NCT06236308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06236308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Phase 1 Dose Finding Study of TTAX03 for the Treatment of Lumbosacral Facet Joint Pain
Lead sponsor
BioTissue Holdings, Inc
Phase
Phase 1
Overall status
Withdrawn
Start date
July 15, 2024
Completion date
March 4, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

facet joint pain